Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCX140-B for albuminuria in type 2 diabetes mellitus
ISRCTN81307356Phase 2Completed
- Sponsor
- ChemoCentryx
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing CCX140-B with Placebo (2 arms). Primary endpoints: Change from baseline in 24-hour urinary albumin excretion over 84 days and Subject incidence of adverse events over 84 days. Started Sep 2011; status: completed.
02
Drugs
ilacirnon
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ISRCTN81307356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN81307356.